Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients

被引：5
作者：
Meszaros, K
Lenzinger, E
Hornik, K
Schonbeck, G
Hatzinger, R
Langer, G
Sieghart, W
Aschauer, HN
机构：
[1] UNIV VIENNA, HOSP PSYCHIAT, DEPT GEN PSYCHIAT, VIENNA, AUSTRIA
[2] VIENNA UNIV ECON, DEPT STAT, VIENNA, AUSTRIA
[3] VIENNA TECH UNIV, INST STAT & WAHRSCHEINLICHKEITSTHEORIE, VIENNA, AUSTRIA
来源：
NEUROPSYCHOBIOLOGY | 1997年 / 36卷 / 02期
关键词：
biperiden plasma levels; haloperidol plasma levels; relation between dose and plasma levels; extrapyramidal side effects; chronic schizophrenia;
D O I：
10.1159/000119365
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Anticholinergic drugs such as biperiden are used for the treatment of extrapyramidal side effects (EPS) induced by neuroleptics such as haloperidol. The effects of biperiden and haloperidol plasma levels on EPS were studied in 29 chronically ill schizophrenics. The results show relationships between biperiden dose and biperiden plasma levels (BPL), and between BPL and haloperidol plasma levels (HPL). Neither BPL nor HPL seem to influence EPS.
引用
收藏
页码：69 / 72
页数：4
相关论文
共 50 条
[21]   The use of nifedipine as a coffector of extrapyramidal side-effects of classical neuroleptics [J].
Popov, M. Yu. .
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (06) :28-33
[22]   Alleviation of extrapyramidal side effects upon switching from risperidone to paliperidone [J].
Prikryl, Radovan .
ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2011, 53 (01) :14-16
[23]   Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers [J].
Christoffersen, CL ;
Meltzer, LT .
NEUROPSYCHOPHARMACOLOGY, 1998, 18 (05) :399-402
[24]   Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects? [J].
Voruganti, LP ;
Awad, AG .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (05) :285-289
[25]   Reversal of haloperidol-induced extrapyramidal side effects in Cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers [J].
Christoffersen C.L. ;
Meltzer L.T. .
Neuropsychopharmacology, 1998, 18 (5) :399-402
[26]   CYPROHEPTADINE AUGMENTATION OF HALOPERIDOL IN CHRONIC-SCHIZOPHRENIC PATIENTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY [J].
LEE, HS ;
SONG, DH ;
KIM, JH ;
LEE, YM ;
HAN, ES ;
YOO, KJ .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) :67-72
[27]   Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice [J].
Devinder Arora ;
Jayesh Mudgal ;
Madhavan Nampoothiri ;
Sanchari Basu Mallik ;
Manas Kinra ;
Susan Hall ;
Shailendra Anoopkumar-Dukie ;
Gary D. Grant ;
Chamallamudi Mallikarjuna Rao .
Metabolic Brain Disease, 2018, 33 :1045-1051
[28]   Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice [J].
Arora, Devinder ;
Mudgal, Jayesh ;
Nampoothiri, Madhavan ;
Mallik, Sanchari Basu ;
Kinra, Manas ;
Hall, Susan ;
Anoopkumar-Dukie, Shailendra ;
Grant, Gary D. ;
Rao, Chamallamudi Mallikarjuna .
METABOLIC BRAIN DISEASE, 2018, 33 (04) :1045-1051
[29]   SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment [J].
Lane, RM .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (02) :192-214
[30]   Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders [J].
Tatara, Ayaka ;
Shimizu, Saki ;
Shin, Noriyuki ;
Sato, Maho ;
Sugiuchi, Tomone ;
Imaki, Junta ;
Ohno, Yukihiro .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 38 (02) :252-259
12345